Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1565
Gene Symbol: CYP2D6
CYP2D6
0.020 GeneticVariation phenotype BEFREE CYP2D6 and ABCB1 polymorphisms were associated with the incidence of dizziness and prolonged corrected QT interval, respectively. 29061081 2017
Entrez Id: 1577
Gene Symbol: CYP3A5
CYP3A5
0.010 Biomarker phenotype BEFREE Women and CYP3A5*1/*1 subjects showed more often dizziness (p = 0.034; p = 0.009). 29325225 2018
Entrez Id: 27342
Gene Symbol: RABGEF1
RABGEF1
0.010 AlteredExpression phenotype BEFREE In this context, we find the Rap1-GEF Dizzy is enriched at the ZA and our results suggest that it promotes Rap1 activity during ZA morphogenesis. 29507112 2018
Entrez Id: 56731
Gene Symbol: SLC2A4RG
SLC2A4RG
0.010 Biomarker phenotype BEFREE In this context, we find the Rap1-GEF Dizzy is enriched at the ZA and our results suggest that it promotes Rap1 activity during ZA morphogenesis. 29507112 2018
Entrez Id: 9181
Gene Symbol: ARHGEF2
ARHGEF2
0.010 Biomarker phenotype BEFREE In this context, we find the Rap1-GEF Dizzy is enriched at the ZA and our results suggest that it promotes Rap1 activity during ZA morphogenesis. 29507112 2018
Entrez Id: 5906
Gene Symbol: RAP1A
RAP1A
0.010 AlteredExpression phenotype BEFREE In this context, we find the Rap1-GEF Dizzy is enriched at the ZA and our results suggest that it promotes Rap1 activity during ZA morphogenesis. 29507112 2018
Entrez Id: 54386
Gene Symbol: TERF2IP
TERF2IP
0.010 AlteredExpression phenotype BEFREE In this context, we find the Rap1-GEF Dizzy is enriched at the ZA and our results suggest that it promotes Rap1 activity during ZA morphogenesis. 29507112 2018
Entrez Id: 348
Gene Symbol: APOE
APOE
0.010 GeneticVariation phenotype BEFREE Moreover, Symptoms like asthma (25%), cough (76.67%), dizziness (36.67%), eye irritation (88.33%), and shortness of breath (43.33%) were highly prevalent among biomass users than in LPG users. 29940511 2018
Entrez Id: 43
Gene Symbol: ACHE
ACHE
0.010 AlteredExpression phenotype BEFREE Abnormal serum AChE levels associated with pesticide exposure are associated with AChE levels and symptoms such as coughing, being tired, dizziness, and dry skin and irritation. 30047860 2018
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.010 GeneticVariation phenotype BEFREE Conversely, LRRK2 G2019S carrier status significantly associated with reporting of milder daily symptoms of lightheadedness and several differences were observed at a false discovery rate < 0.1, including increased reporting of changes in walking as an initial symptom of disease, decreased reporting of lightheadedness upon standing, and milder symptoms related to daily functioning. 30154511 2018
Entrez Id: 2915
Gene Symbol: GRM5
GRM5
0.010 Biomarker phenotype BEFREE Adverse events incidence was higher with mGluR5 antagonists than with placebo, especially at the expense of increased dizziness (16.3 vs. 4.3%), visual hallucination (10.1 vs. 1.1%), or fatigue (10.1 vs. 4.8%). 30271338 2018
Entrez Id: 4988
Gene Symbol: OPRM1
OPRM1
0.010 GeneticVariation phenotype BEFREE The aim of this meta-analysis is to identify the predictive strength in the current literature of OPRM1-A118G polymorphism to postoperative anesthetic reactions, including nausea, vomiting, pruritus and dizziness. 30323865 2018
Entrez Id: 64374
Gene Symbol: SIL1
SIL1
0.010 Biomarker phenotype BEFREE To study PNS vulnerability in MSS, intramuscular nerves fibres from MSS patients and from SIL1-deficient mice (woozy) as well as sciatic nerves and neuromuscular junctions (NMJ) from these mice have been investigated via transmission electron microscopic and immunofluorescence studies accompanied by transcript studies and unbiased proteomic profiling. 30468864 2019
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.010 Biomarker phenotype BEFREE Accordingly, DB is often underdiagnosed or misdiagnosed, given the similarity of its associated symptoms (dyspnea, tachycardia, and dizziness) to those of other common cardiopulmonary diseases such as COPD and asthma. 30758427 2019
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.010 Biomarker phenotype BEFREE Sixty-eight patients with AC/V-P shunts had a higher incidence of head trauma (P = 0.014), younger age at onset (P < 0.001), and lower incidence of dizziness (P = 0.013) than did those without AC/V-P shunts. 30797913 2019
Entrez Id: 9311
Gene Symbol: ASIC3
ASIC3
0.010 GeneticVariation phenotype BEFREE However, whether the genetic variants of <i>ASIC3</i> are associated with people who suffer dizziness and balance impairment after mTBI remained unknown. 30804886 2019
Entrez Id: 80025
Gene Symbol: PANK2
PANK2
0.010 AlteredExpression phenotype BEFREE For HSS, the active group showed reduced hangover symptoms while there were higher levels of nausea, headache, anorexia, tremulousness, diarrhoea and dizziness in the placebo group (p < 0.05) at hour 10 post-intoxication. 30922154 2019
Entrez Id: 6448
Gene Symbol: SGSH
SGSH
0.010 AlteredExpression phenotype BEFREE For HSS, the active group showed reduced hangover symptoms while there were higher levels of nausea, headache, anorexia, tremulousness, diarrhoea and dizziness in the placebo group (p < 0.05) at hour 10 post-intoxication. 30922154 2019
Entrez Id: 9043
Gene Symbol: SPAG9
SPAG9
0.010 AlteredExpression phenotype BEFREE For HSS, the active group showed reduced hangover symptoms while there were higher levels of nausea, headache, anorexia, tremulousness, diarrhoea and dizziness in the placebo group (p < 0.05) at hour 10 post-intoxication. 30922154 2019
Entrez Id: 2697
Gene Symbol: GJA1
GJA1
0.010 AlteredExpression phenotype BEFREE For HSS, the active group showed reduced hangover symptoms while there were higher levels of nausea, headache, anorexia, tremulousness, diarrhoea and dizziness in the placebo group (p < 0.05) at hour 10 post-intoxication. 30922154 2019
Entrez Id: 2671
Gene Symbol: GFER
GFER
0.010 AlteredExpression phenotype BEFREE For HSS, the active group showed reduced hangover symptoms while there were higher levels of nausea, headache, anorexia, tremulousness, diarrhoea and dizziness in the placebo group (p < 0.05) at hour 10 post-intoxication. 30922154 2019
Entrez Id: 1523
Gene Symbol: CUX1
CUX1
0.010 Biomarker phenotype BEFREE Patients were assessed with objective outcome measures (sensorial organization test and limits of stability-LOS-of CDP, modified timed up and go test-TUG-and number of falls) and with subjective outcome measures (dizziness handicap inventory and Short falls efficacy scale-international-Short FES-I) during a 12-month follow-up period. 30977081 2020
Entrez Id: 4878
Gene Symbol: NPPA
NPPA
0.010 Biomarker phenotype BEFREE Patients were assessed with objective outcome measures (sensorial organization test and limits of stability-LOS-of CDP, modified timed up and go test-TUG-and number of falls) and with subjective outcome measures (dizziness handicap inventory and Short falls efficacy scale-international-Short FES-I) during a 12-month follow-up period. 30977081 2020
Entrez Id: 8864
Gene Symbol: PER2
PER2
0.010 Biomarker phenotype BEFREE This was an interventional study using medical records to collect data for acute dizziness presentations before (period 1, 2012-2014) and after (period 2, 2016-2017) the implementation of a management algorithm. 31098875 2019
Entrez Id: 83932
Gene Symbol: SPRTN
SPRTN
0.010 Biomarker phenotype BEFREE Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials. 31152441 2019